Academic outcomes in Asian children aged 8–11 years with attention-deficit/hyperactivity disorder treated with atomoxetine hydrochloride

References

• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Text Revision (DSM-IV-TR). Washington, DC: American Psychiatric Press; 2000.
   Google Scholar
• Barbaresi WJ, Katusic SK, Colligan RC, Weaver AL, Jacobsen SJ. Long-term school outcomes for children with attention-deficit/hyperactivity disorder: a population-based perspective. J Dev Behav Pediatr 2007;28:265–73.
   PubMed Web of Science ®Google Scholar
• Barkley RA. Major life activity and health outcomes associated with attention-deficit/hyperactivity disorder. J Clin Psychiatry 2002;63:10–15.
   PubMed Web of Science ®Google Scholar
• Loe IM, Feldman HM. Academic and educational outcomes of children with ADHD. J Pediatr Psychol 2007;32: 643–54.
   PubMed Web of Science ®Google Scholar
• Evans SW, Pelham WE, Smith BH, Bukstein O, Gnagy E, Greiner AR, . Dose–response effects of methylphenidate on ecologically valid measures of academic performance and classroom behavior in adolescents with ADHD. Exp Clin Psychopharmacol 2001;9:163–75.
   PubMed Web of Science ®Google Scholar
• Swanson JM, Cantwell D, Lerner M, McBurnett K, Hanna G. Effects of stimulant medication on learning in children with ADHD. J Learn Disabil 1991;24:219–30, 255.
   PubMed Web of Science ®Google Scholar
• Merrell C, Tymms PB. Inattention, hyperactivity and impulsiveness: their impact on academic achievement and progress. Br J Educ Psychol 2001;71:43–56.
   PubMed Web of Science ®Google Scholar
• Scheffler RM, Brown TT, Fulton BD, Hinshaw SP, Levine P, Stone S. Positive association between attention-deficit/ hyperactivity disorder medication use and academic achievement during elementary school. Pediatrics 2009; 123:1273–9.
   PubMed Web of Science ®Google Scholar
• Jitendra AK, Dupaul GJ, Someki F, Tresco KE. Enhancing academic achievement for children with Attention-Deficit Hyperactivity Disorder: evidence from school-based intervention research. Dev Disabil Res Rev 2008;14:325–30.
   PubMed Web of Science ®Google Scholar
• Garnock-Jones KP, Keating GM. Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents. Paediatr Drugs 2009;11:203–26.
   PubMedGoogle Scholar
• Newcorn JH, Sutton VK, Weiss MD, Sumner CR. Clinical responses to atomoxetine in attention-deficit/hyperactivity disorder: the Integrated Data Exploratory Analysis (IDEA) study. J Am Acad Child Adolesc Psychiatry 2009;48:511–8.
   PubMed Web of Science ®Google Scholar
• Gau SS, Chiu CD, Shang CY, Cheng AT, Soong WT. Executive function in adolescence among children with attention-deficit/hyperactivity disorder in Taiwan. J Dev Behav Pediatr 2009;30:525–34.
   PubMed Web of Science ®Google Scholar
• Biederman J, Monuteaux MC, Doyle AE, Seidman LJ, Wilens TE, Ferrero F, . Impact of executive function deficits and attention-deficit/hyperactivity disorder (ADHD) on academic outcomes in children. J Consult Clin Psychol 2004;72:757–66.
   PubMed Web of Science ®Google Scholar
• Kempton S, Vance A, Maruff P, Luk E, Costin J, Pantelis C. Executive function and attention deficit hyperactivity disorder: stimulant medication and better executive function performance in children. Psychol Med 1999;29:527–38.
   PubMed Web of Science ®Google Scholar
• Barnett R, Maruff P, Vance A, Luk ES, Costin J, Wood C, . Abnormal executive function in attention deficit hyperactivity disorder: the effect of stimulant medication and age on spatial working memory. Psychol Med 2001;31:1107–15.
   PubMed Web of Science ®Google Scholar
• Bymaster FP, Katner JS, Nelson DL, Hemrick-Luecke SK, Threlkeld PG, Heiligenstein JH, . Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder. Neuropsychopharmacology 2002;27:699–711.
   PubMed Web of Science ®Google Scholar
• Barton J, Mooney P, Prasad S. Atomoxetine hydrochloride and executive function in children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 2005;15:147–9.
   PubMed Web of Science ®Google Scholar
• Brown TE, Holdnack J, Saylor K, Adler L, Spencer T, Williams DW, . Effect of Atomoxetine on Executive Function Impairments in Adults With ADHD. J Attent Disord 2009 [Epub ahead of print].
   Web of Science ®Google Scholar
• DuPaul GJ, Power TJ, Anastopoulos AD, Reid R. ADHD Rating Scale-IV. Checklist, Norms, and Clinical Interpretations. New York, NY: The Guilford Press; 1998.
   Google Scholar
• Wang Y, Zheng Y, Du Y, Song DH, Shin YJ, Cho SC, . Atomoxetine versus methylphenidate in paediatric outpatients with attention deficit hyperactivity disorder: a randomized, double-blind comparison trial. Aust NZ J Psychiatry 2007;41:222–30.
   PubMed Web of Science ®Google Scholar
• Gau SS, Huang YS, Soong WT, Chou MC, Chou WJ, Shang CY, . A randomized, double-blind, placebo-controlled clinical trial on once-daily atomoxetine in Taiwanese children and adolescents with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 2007;17:447–60.
   PubMed Web of Science ®Google Scholar
• Guy W. ECDEU Assessment Manual for Psychopharmacology, Revised. Bethesda, MD: US Department of Health, Education, and Welfare; 1976.
   Google Scholar
• Conners CK, Sitarenios G, Parker JD, Epstein JN. The revised Conners’ Parent Rating Scale (CPRS-R): factor structure, reliability, and criterion validity. J Abnorm Child Psychol 1998;26:257–68.
   PubMed Web of Science ®Google Scholar
• Cohen J, Cohen P, West S, Aiken L. Applied multiple regression/correlation analysis for the behavioural sciences. 3rd. Mahwah, NJ: Lawrence Erlbaum Associates; 2003. 19–63.
   Google Scholar
• Cho SC, Lee SI, Yoo H, Song DH, Ahn H-H, Shin DW, . A randomized, open-label assessment of response to various doses of atomoxetine in Korean pediatric outpatients with attention-deficit/hyperactivity disorder. Psychiatry Invest (in press).
   Web of Science ®Google Scholar
• Wietecha LA, Williams DW, Herbert M, Melmed RD, Greenbaum M, Schuh K. Atomoxetine treatment in adolescents with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 2009;19:719–30.
   PubMed Web of Science ®Google Scholar
• Dickson RA, Lee B, Turgay A, Chang S, White H, Davis L, . Canada atomoxetine treatment of ADHD: Symptomatic, academic, cognitive, and functional outcomes. Paper presented at American Academy of Child and Adolescent Psychiatry (AACAP) 54th Annual Meeting, 23–28 October 2007, Boston, MA.
   Google Scholar
• MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. Arch Gen Psychiatry 1999;56:1073–86.
   PubMed Web of Science ®Google Scholar
• MTA Cooperative Group. National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: 24-month outcomes of treatment strategies for attention-deficit/hyperactivity disorder. Pediatrics 2004; 113:754–61.
   PubMed Web of Science ®Google Scholar